Jump to navigation
Title 21 published on 2014-04-01
no entries appear in the Federal Register after this date.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
§ 321 - Definitions; generally
§ 348 - Food additives
§ 351 - Adulterated drugs and devices
§ 352 - Misbranded drugs and devices
§ 355 - New drugs
21 U.S. Code § 221 to 237 - Repealed. July 1, 1944, ch. 373, title XIII,
§ 355a - Pediatric studies of drugs
§ 355b - Adverse-event reporting
§ 355c - Research into pediatric uses for drugs and biological products
§ 355d - Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
§ 355e - Pharmaceutical security
§ 356 - Expedited approval of drugs for serious or life-threatening diseases or conditions
§ 356a - Manufacturing changes
§ 356b - Reports of postmarketing studies
§ 356c - Discontinuance or interruption in the production of life-saving drugs
§ 357 - Repealed.
§ 361 - Adulterated cosmetics
§ 362 - Misbranded cosmetics
§ 371 - Regulations and hearings
§ 374 - Inspection
§ 4332 - Cooperation of agencies; reports; availability of information; recommendations; international and national coordination of efforts